Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3

Clinical trial NCT03485677 · COMPLETED

Trial details

NCT number: NCT03485677
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gaucher's Disease Type I Gaucher's Disease Type III

Start date: 2018-04-11
Primary completion: 2025-12-26
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.